ScholarIQanswers from OpenAlex & ORCID
Susan E. Bates
ResearcherPublications, citations & collaboration network
Susan E. Bates is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Susan E. Bates have?
ScholarIQindexed works
Susan E. Bates has 955 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Susan E. Bates have?
ScholarIQcitation count
Susan E. Bates has 52,187 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Susan E. Bates?
ScholarIQh-index
Susan E. Bates has an h-index of 111 in OpenAlex.
What is the i10-index of Susan E. Bates?
ScholarIQi10-index
Susan E. Bates has an i10-index of 369 in OpenAlex.
What is the ORCID of Susan E. Bates?
ScholarIQorcid
The ORCID for Susan E. Bates is on the source record.
What is the OpenAlex record for Susan E. Bates?
ScholarIQopenalex
The OpenAlex for Susan E. Bates is on the source record.
What are the most-cited papers on Susan E. Bates?
ScholarIQmost cited works
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz‐Josef Klümpen, Stephen L. Chan, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Arndt Vogel, Arndt Vogel, Mehmet Akce, Inmaculada Alés Díaz, Gustavo R. Alves, Sumitra Anand, Çağatay Arslan, Jamil Asselah, Eric Assenat, F. Aubin, Li‐Yuan Bai, Yuxian Bai, Olga Barajas, Susan E. Bates, Stephen Begbie, Irit Ben‐Aharon, Nina Beri, Marie‐Luise Berres, Jean‐Frédéric Blanc, Ivan Borbath, Robert Bordonaro, Mohamed Bouattour, Giovanni Brandi, Adam M. Burgoyne, Kritiya Butthongkomvong, Marcos Pedro Guedes Camandaroba, Ke Cao, Marcela Carballido, Jen‐Shi Chen, Jen‐Shi Chen, Ming-Huang Chen, Ashley Cheng, Ashley Cheng, Tai‐Jan Chiu, Hye Jin Choi, Hong Jae Chon, Joëlle Collignon, Antonio Cubillo Gracián, S. Lindsey Davis, Ricardo Saraiva de Carvalho, D.J.A. de Groot, Anne Demols, Judith de Vos, Maria Diab, Jacob C. Easaw, Martin Eatock, Julien Edeline, Rawad Elias, Fredericus Eskens, Alfredo Falcone, Plinio Fernández, Richard Finn, Fábio Franke, Masayuki Furukawa, Junji Furuse, Olumide B. Gbolahan, Karen Geboes, Keri-Lee Geneser, Zhimin Geng, Ravit Geva, Roopinder Gillmore, Thorsten Oliver Goetze, Hongfeng Gou, Julieta Grasselli, Shanzhi Gu, Mahmut Gümüş, Nadia Haj Mohammad, Chunyi Hao, Hakan Harputluoğlu, Hassan Hatoum, Volker Heinemann, Wang Kwong Ho, Chiun Hsu, Ayala Hubert, Jun‐Eul Hwang, Mevlüde İnanç, Soledad Iseas, Vaishnavi Jeyasingam, Paula Jiménez Fonseca, Warren Joubert
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas, Christophe E. Redon, Linda Sciuto, Emerson Padiernos, Jiuping Ji, Min-Jung Lee, Akira Yuno, Sunmin Lee, Yiping Zhang, Lan Tran, William H. Yutzy, Arun Rajan, Udayan Guha, Haobin Chen, Raffit Hassan, Christine Alewine, Éva Szabó, Susan E. Bates, Robert J. Kinders, Seth M. Steinberg, James H. Doroshow, Mirit I. Aladjem, Jane B. Trepel, Yves Pommier